Tumour cell detection in G-CSF mobilised stem cell harvests of patients with breast cancer
- 1 April 1999
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 16 (1) , 17-22
- https://doi.org/10.1007/bf02787354
Abstract
Peripheral blood stem cells were mobilised with G-CSF from steady-state haemopoiesis after previous anthracyclin-containing standard dose chemotherapy in patients with high-risk breast cancer. 48 samples were obtained from patients with stage II–III breast cancer and ≥10 lymph nodes, 15 samples from patients with chemotherapy sensitive metastatic disease, and 13 samples from women with inflammatory breast cancer. 44 samples were first or single leukaphereses and 32 samples were second or third harvests. Aliquots were searched for contaminating tumour cells by immunocytochemistry (IC) and cytokeratin-19 reverse transcriptase polymerase chain reaction (rtPCR). The median count of MNCs examined by IC was 2×106; cDNA prepared from 2×107 cells was subjected to PCR. Fifty-nine samples were examined by immunocytochemistry, 36 samples by rtPCR, and 19 samples by both techniques. Samples investigated by IC and rtPCR were judged as positive if there was at least one positive test. On the whole, 42/79 (55.3%) of the samples were positive with an insignificant trend to a higher positivity rate in second or subsequent leukaphereses (52.3% vs 59.3%). The median tumour cell load per 106 MNCs was low with 0.5(0–7) cells in all, and a total of 2.2 (0.5–7) cells in positive specimen. Differences in the cancer cell load of first and subsequent leukaphereses and between subgroups of patients were not found. PCR and IC gave consistent results in 63.2%. This phenomenon can be explained by the greater sensitivity of the molecular method and by a Poisson distribution of coharvested tumour cells in samples. Tumour cell contamination in G-CSF mobilised stem cells from patients with breast cancer from steady state haemopoiesis after preceding anthacyclin-containing chemotherapy is frequent, but the tumour cell load is low. To allow a comparison of different studies dealing with cancer cell contamination in stem cells, standardisation of assays is necessary.Keywords
This publication has 26 references indexed in Scilit:
- Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitroBritish Journal of Cancer, 1998
- Comparison of Molecular Cytokeratin 19 Reverse Transcriptase Polymerase Chain Reaction (CK19 RT-PCR) and Immunocytochemical Detection of Micrometastatic Breast Cancer Cells in Hematopoietic HarvestsJournal of Hematotherapy, 1997
- Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patientsBone Marrow Transplantation, 1997
- [Significance of stem cell-supported high-dose chemotherapy in the treatment of gynecological malignancies: indications and current clinical trials in the Federal Republic of Germany].1997
- Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patientsZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Micrometastases and TransplantationJournal of Hematotherapy, 1996
- High Dose versus Standard Dose Chemotherapy for the Treatment of Breast CancerAnnals of the New York Academy of Sciences, 1995
- Prognostic factors in breast carcinomaCurrent Opinion in Obstetrics and Gynecology, 1995
- Multidisciplinary management of advanced primary and metastatic breast cancerCancer, 1994
- Comparison of the Growth and Metastasis of Four Human Intestinal Tumor Cell Line XenograftsTumor Biology, 1989